Use of Smart Drugs in Cancer Treatment

Smart drugs are biotechnological medications that are considered a revolutionary advancement in cancer treatment, directly targeting cancer cells while avoiding damage to healthy cells. These drugs aim to neutralize cancer cells by analyzing their genetic and molecular characteristics. Unlike conventional chemotherapy, they have fewer side effects and enable personalized treatment.

The first targeted cancer therapies were developed in the early 2000s. Thanks to advances in molecular biology and genetics, smart drugs capable of acting on specific features of cancer cells began to be produced. Today, these drugs have become one of the standard treatment options for many types of cancer.

Smart drugs target specific proteins or genetic mutations that drive the growth and proliferation of cancer cells. The main mechanisms used are as follows:

Tyrosine Kinase Inhibitors (TKIs): Block signaling pathways that promote cancer cell growth.

Monoclonal Antibodies: Bind to specific proteins on the surface of cancer cells, enabling the immune system to recognize and eliminate them.

Immune Checkpoint Inhibitors: Block mechanisms that suppress the immune system, thereby facilitating the destruction of cancer cells by the body’s immune response.

Smart drugs are used in many types of cancer, including lung, breast, colon, skin (melanoma), and blood cancers (leukemia and lymphoma). These medications are selected based on the genetic profile of the tumor, offering personalized treatment options.

In recent years, Türkiye has made significant progress in developing the active ingredients of smart drugs using local capabilities. Local biotechnology companies and universities are conducting research to produce molecules used in cancer treatment. The goal is to provide cancer patients with more accessible and affordable therapeutic options.

^{Smart Drug-}AA

• Targets cancer cells without harming healthy cells.
• Has fewer side effects compared to conventional chemotherapy.
• Enables personalized treatment.
• Promotes more effective and longer-lasting responses.

• Is expensive.
• Has limited effectiveness against some types of cancer.
• Carries a risk of resistance development.

Smart drugs in cancer treatment represent the latest advancement in personalized medicine and biotechnology. The development of next-generation drugs and the expansion of local production capabilities are regarded as a major turning point in cancer therapy.